Skip to main content
  1. Market Insights
  2. Health
  3. Hospitals
  4. Inpatient Care

Treatment of Musculoskeletal Diseases - Benelux

Benelux
  • In the Benelux region, the Treatment of Musculoskeletal Diseases market is expected to witness significant growth.
  • By 2024, the projected revenue is estimated to reach US$3.42bn.
  • Looking ahead, the market is anticipated to display a steady annual growth rate (CAGR 2024-2029) of 1.93%, leading to a market volume of US$3.77bn by 2029.
  • When compared globally, it is noteworthy that United States is expected to generate the highest revenue in the Treatment of Musculoskeletal Diseases market.
  • In 2024 alone, United States is projected to generate a staggering US$60.79bn.
  • In the Benelux region, there is a growing preference for non-surgical treatments for musculoskeletal diseases, such as physical therapy and alternative medicine.

Definition:
Treatments of Musculoskeletal Diseases refer to medical care and/or surgical procedures provided to patients who require hospitalization due to severe or complex musculoskeletal conditions, such as fractures, joint replacements, or degenerative diseases. The causes of these diseases range from senile decay and genetic inheritance to injuries. The goal of inpatient musculoskeletal care is to promote healing, restore function, and provide strategies for pain management of the affected area.

Additional information:
The Treatments of Musculoskeletal Diseases market comprises revenues and average revenue per capita. Market values represent revenues paid to hospitals by the respective healthcare payers (including VAT, if applicable). Reported market revenues include spending by consumers (B2C), enterprises (B2B), and governments (B2G). Revenues are allocated to the country where the money is spent.

In-Scope

  • Diagnostic tests
  • Surgical procedures, such as joint replacements, spinal surgeries, and orthopedic surgeries
  • Pain management and control
  • Physical therapy
  • Monitoring and management of post-surgical complications

Out-Of-Scope

  • Outpatient diagnostic tests and procedures
  • Home health care services and support
Back pain in the U.S. - Cover

Statistics report about back pain in the United States

Back pain in the U.S.

Study Details

    Revenue

    Notes: Data shown is using current exchange rates and reflects market impacts of the Russia-Ukraine war.

    Most recent update: Apr 2024

    Source: Statista Market Insights

    Most recent update: Apr 2024

    Source: Statista Market Insights

    Global Comparison

    Most recent update: Apr 2024

    Source: Statista Market Insights

    Methodology

    Data coverage:

    Data encompasses B2B, B2G, and B2C spend. Figures are based on revenue received by hospitals from public or private sources, allocated to the country where the money is spent, including VAT if applicable.

    Modeling approach / Market size:

    Market sizes are determined by a bottom-up approach, based on a specific rationale for each market market. Next, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per capita, health risk factors, public health spend, and GDP. This data helps us estimate the market size for each country individually.

    Forecasts:

    In our forecasts, we apply diverse forecasting techniques. The selection of techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods.

    Additional notes:

    Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level.

    Health

    Access more Market Insights on Health topics with our featured report

    Back pain in the U.S. - BackgroundBack pain in the U.S. - Cover

    Key Market Indicators

    Notes: Based on data from IMF, World Bank, UN and Eurostat

    Most recent update: Sep 2024

    Source: Statista Market Insights

    Explore more high-quality data on related topic

    Chronic pain and rheumatic diseases in Europe - statistics & facts

    Rheumatic diseases include ailments such as osteoarthritis, rheumatoid arthritis, and gout which in severe cases can leave the sufferer unable to do basic daily tasks. Chronic pain has been defined as pain that lasts longer than three months despite the use of medication or therapy. Rheumatic diseases commonly cause chronic pain, although there are more conditions that can be the cause, such as back pain, fibromyalgia, and nerve damage. In particular, back pain is becoming an increasingly common problem in Europe due to, in part, inactive lifestyles.
    More data on the topic

    Contact

    Get in touch with us. We are happy to help.